A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles

详细信息    查看全文

• 作者：Ying Xu ; Nian-Zhang Zhang ; Meng Wang ; Hu Dong ; Sheng-Yong Feng…
• 关键词：Toxoplasma gondii ; Toxoplasmosis ; Rhoptry protein 38 ; Rhoptry protein 18 ; Poly (lactide ; co ; glycolide) microparticles ; Protective immunity
• 刊名：Parasitology Research
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：114
• 期：11
• 页码：4195-4203
• 全文大小：778 KB
• 参考文献：Acharya AP, Lewis JS, Keselowsky BG (2013) Combinatorial co-encapsulation of hydrophobic molecules in poly (lactide-co-glycolide) microparticles. Biomaterials 34:3422-430PubMed Central CrossRef PubMed
  Boothroyd JC, Dubremetz JF (2008) Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat Rev Microbiol 6:79-8CrossRef PubMed
  Chuang SC, Ko JC, Chen CP, Du JT, Yang CD (2013a) Encapsulation of chimeric protein rSAG1/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice. Exp Parasitol 134:430-37CrossRef PubMed
  Chuang SC, Ko JC, Chen CP, Du JT, Yang CD (2013b) Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. Parasit Vectors 6:34PubMed Central CrossRef PubMed
  Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159:1903-908PubMed
  D??kaya M, Kalantari-Dehaghi M, Walsh CM, Hiszczyńska-Sawicka E, Davies DH, Felgner PL, Larsen LS, Lathrop RH, Hatfield GW, Schulz JR, Gürüz Y, Jurnak F (2007) GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine. Vaccine 25:1824-7CrossRef PubMed
  Dubey JP (2009) Toxoplasmosis in pigs—the last 20?years. Vet Parasitol 164:89-03CrossRef PubMed
  Dubey JP (2010) Toxoplasmosis of animals and humans, 2nd edn. CRC Press Inc, Boca Raton, Florida, pp 1-13
  Fentress SJ, Sibley LD (2011) The secreted kinase ROP18 defends Toxoplasma’s border. Bioessays 33:693-00PubMed Central CrossRef PubMed
  Fentress SJ, Steinfeldt T, Howard JC, Sibley LD (2012) The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii. Cell Microbiol 14:1921-3PubMed Central CrossRef PubMed
  Gjerde B, Josefsen TD (2015) Molecular characterisation of Sarcocystis lutrae n. sp. and Toxoplasma gondii from the musculature of two Eurasian otters (Lutra lutra) in Norway. Parasitol Res 114:873-86CrossRef PubMed
  Guo HC, Sun SQ, Jin Y, Yang SL, Wei YQ, Sun DH, Yin SH, Ma JW, Liu ZX, Guo JH, Luo JX, Yin H, Liu XT, Liu DX (2013) Foot-and mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res 44:48PubMed Central CrossRef PubMed
  Innes EA, Vermeulen AN (2006) Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133:S145-68CrossRef PubMed
  Innes EA, Bartley PM, Maley SW, Wright SE, Buxton D (2007) Comparative host-parasite relationships in ovine toxoplasmosis and bovine neosporosis and strategies for vaccination. Vaccine 25:5495-503CrossRef PubMed
  Jain S, O’Hagan DT, Singh M (2011) The long-term potential of biodegradable poly (lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant. Expert Rev Vaccines 10:1731-742CrossRef PubMed
  Jeffery H, Davis SS, O’Hagan DT (1993) The preparation and characterization of poly (lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res 10:362-68CrossRef PubMed
  Jongert E, Roberts CW, Gargano N, F?rster-Waldl E, Petersen E (2009) Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 104:252-6CrossRef PubMed
  Jongert E, Lemiere A, Van Ginderachter J, De Craeye S, Huygen K, D’Souza S (2010) Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells. Vaccine 28:2556-564CrossRef PubMed
  Lang C, Gross U, Lüder CG (2007) Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 100:191-03CrossRef PubMed
  Matowicka-Karna J, Dymicka-Piekarska V, Kemona H (2009) Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol 2009:374696PubMed Central CrossRef PubMed
  Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965-976CrossRef PubMed
  Niedelman W, Sprokholt JK, Clough B, Frickel EM, Saeij JP (2013) Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication. Infect Immun 81:4341-349PubMed Central CrossRef PubMed
  Petersen E (2007) Toxoplasmosis. Semin Fetal Neonatal Med 12:214-23CrossRef PubMed
  Qu D, Han J, Du A (2013) Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp Parasitol 135:234-39CrossRef PubMed
  Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxop
• 作者单位：Ying Xu (1) (2)
  Nian-Zhang Zhang (1)
  Meng Wang (1)
  Hu Dong (1)
  Sheng-Yong Feng (1)
  Hui-Chen Guo (1)
  Xing-Quan Zhu (1) (3)
  
  1. State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, 730046, People’s Republic of China
  2. Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People’s Republic of China
  3. Jiangsu Co-innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University College of Veterinary Medicine, Yangzhou, Jiangsu Province, 225009, People’s Republic of China
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Medical Microbiology
  Microbiology
  Immunology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-1955

文摘

Toxoplasma gondii infection in humans and animals is a worldwide zoonosis. Prevention and control of toxoplasmosis based on vaccination is one of the promising strategies. In the present study, recombinant T. gondii rhoptry proteins 38 and 18 (TgROP38 and TgROP18) were encapsulated into poly (lactide-co-glycolide) (PLG) (1:1), respectively, to obtain the stable water-in-oil-in-water double emulsion. Female Kunming mice were then immunized with the protein vaccines twice at a 2-week interval. Eight weeks after the second immunization, 10 mice from each group were challenged with T. gondii PRU strain (genotype II). The entrapment rates of PLG-rROP38 and PLG-rROP18 ranged from 65.5 to 77.7 % and 58.1 to 72.3 %, respectively. Immunization of mice with rROP38 and rROP18 proteins encapsulated into PLG microparticles elicited strongly humoral and cell-mediated responses against T. gondii, associated with relatively high levels of total IgG, IgG2a isotype, and IFN-γ, as well as the mixed Th1/Th2 immunity responses. Immunization with various protein vaccines induced significant reduction of the brain cysts after chronic infection with the T. gondii PRU strain, and the most effective protection was achieved in the PLG-rROP38-rROP18-immunized mice, with a cyst reduction of 81.3 %. The findings of the present study indicated that recombinant rhoptry antigens encapsulated in PLG could maintain the protein immunogenicity in an extended period and elicit effective protection against chronic T. gondii infection, which has implications for the development of long-lasting vaccines against chronic toxoplasmosis in animals. Keywords Toxoplasma gondii Toxoplasmosis Rhoptry protein 38 Rhoptry protein 18 Poly (lactide-co-glycolide) microparticles Protective immunity